1-2 of 2
Tai-Tsang Chen
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Dasatinib Is Well-Tolerated and Efficacious in Imatinib-Intolerant Patients with Chronic-Phase Chronic Myeloid Leukemia (CP-CML).

Hanna Jean Khoury, MD, Michael J. Mauro, MD, Yousif Matloub, MD, Tai-Tsang Chen, PhD, Erkut Bahceci, MD, Michael Deininger, MD, PhD
Journal: Blood
Blood (2009) 114 (22): 1128.
https://doi.org/10.1182/blood.V114.22.1128.1128
Published: 2009
Journal Articles

Importance of Early Intervention with Dasatinib at Cytogenetic Rather Than Hematologic Resistance to Imatinib.

Hagop M. Kantarjian, MD, Alfonso Quintas-Cardama, MD, Susan O’Brien, MD, Farhad Ravandi, MD, Gautam Borthakur, MD, David Liu, MD, Tai-Tsang Chen, Jorge Cortes, MD
Journal: Blood
Blood (2007) 110 (11): 1036.
https://doi.org/10.1182/blood.V110.11.1036.1036
Published: 2007